Delivery Order SPE2DB24D3013-SPE2DB24FFHNL
Award Date
9/5/24
Potential Completion Date
9/6/24
Potential Value
$6.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $63,270.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for the supply of 4,565,425,799 doses of the BOOSTRIX TDAP vaccine in 0.5mL syringes. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,021.76 firm-fixed price contract is for the supply of 4,565,913,991 units of the BOOSTRIX TDAP vaccine syringe 0.5 mL. The contract has an ultimate completion date of September 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities, including...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,092,038 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract has a firm fixed price of $16,764.30 and a completion date of May 1, 2025. This contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) has awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,176,760 units of the BOOSTRIX TDAP vaccine syringe (0.5 ml) at a ceiling value of $4,228.80. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide 4,565,725,440 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL) at a firm fixed price of $24,001.40. The award has an ultimate completion date of September 10, 2024 and is not set aside for any specific business type. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,250,565 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL) with a potential value of $2,251.46. The delivery order has a completion date of January 8, 2024 and was awarded on January 5, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, through its Corporate Office...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,570,475 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a ceiling value of $11,899.50. The delivery order has a firm fixed price and an ultimate completion date of February 6, 2024. The contract was awarded on February 5, 2024, and there was no set-aside designation used. Amerisourcebergen...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The order is for 4,565,365,606 units of the BOOSTRIX TDAP vaccine syringe, a 0.5 mL dose of the tetanus, diphtheria, and acellular pertussis vaccine. The contract has a firm fixed price of $1,877.65 and a completion date of August 7, 2024. AmerisourceBergen is a major pharmaceutical distributor...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,446,070 units of the BOOSTRIX TDAP vaccine syringe (0.5 ml). The firm-fixed-price contract is valued at $1,053.96 and has an ultimate completion date of November 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,443,055 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The order has a ceiling value of $5,322.00 and an ultimate completion date of May 7, 2025. The contract is not set aside and was awarded on May 6, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management...